Y-90 LABELED MONOCLONAL-ANTIBODIES FOR CANCER-THERAPY

被引：0
|
作者：
WASHBURN, LC [1 ]
SUN, TTH [1 ]
CROOK, JE [1 ]
BYRD, BL [1 ]
CARLTON, JE [1 ]
HUNG, YW [1 ]
STEPLEWSKI, ZS [1 ]
机构：
[1] WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104
来源：
NUCLEAR MEDICINE AND BIOLOGY | 1986年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：453 / 456
页数：4
相关论文
共 50 条
  • [21] Y-90 FOR CANCER-THERAPY STUDIES SECURED THROUGH GOVERNMENT AND COMMERCIAL SUPPLIERS
    TILYOU, SM
    JOURNAL OF NUCLEAR MEDICINE, 1991, 32 (02) : N16 - &
  • [22] THE PRODUCTION AND BIOLOGICAL DISTRIBUTION OF Y-90 LABELED ANTIBODIES
    VAUGHAN, ATM
    KEELING, A
    YANKUBA, SCS
    INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES, 1985, 36 (10): : 803 - 806
  • [23] PREPARATION OF Y-90 LABELED ANTIBODIES FOR PATIENT USE
    CHINOL, M
    VIRZI, F
    DOHERTY, PW
    HNATOWICH, DJ
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 959 - 960
  • [24] MINIMAL RESIDUAL DISEASE - A TARGET FOR RADIOIMMUNOTHERAPY WITH I-131 OR Y-90 LABELED MONOCLONAL-ANTIBODIES - SOME DOSIMETRIC CONSIDERATIONS
    HERBOLD, G
    SAUTTERBIHL, ML
    DORR, U
    BIHL, H
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1992, 19 (08): : 610 - 610
  • [25] ELECTRON-MICROSCOPIC STUDY ON THE USE OF MONOCLONAL-ANTIBODIES FOR CANCER-THERAPY
    KUSANO, A
    SHITARA, K
    HANAI, N
    JOURNAL OF ELECTRON MICROSCOPY, 1991, 40 (04): : 282 - 282
  • [26] ANTIBODIES LABELED WITH IN-111 AND Y-90 FOR CLINICAL USE
    EPENETOS, AA
    BRITISH JOURNAL OF CANCER, 1986, 54 (03) : 532 - 533
  • [27] Y-90 LABELED ANTIBODIES - THE INFLUENCE OF DTPA ON DOSE DISTRIBUTION
    FARNSWORTH, APH
    VAUGHAN, ATM
    JOURNAL OF NUCLEAR MEDICINE, 1988, 29 (07) : 1326 - 1326
  • [28] Lung shunting in therapy with Y-90 labeled glass microspheres for liver cancer
    Ruano, R.
    Barquero Sanz, M.
    Rodriguez, D.
    Gamazo, C.
    de la LLana, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S584 - S585
  • [29] Radioimmunotherapy of glioblastoma by using I-131 and Y-90 labeled antitenascin Monoclonal Antibodies.
    Riva, P
    Franceschi, G
    Frattarelli, M
    Riva, N
    Guiducci
    Cremonini, AM
    Giuliani, G
    Casi, M
    Gentile, R
    RADIOACTIVE ISOTOPES IN CLINICAL MEDICINE AND RESEARCH XXIII, 1999, : 59 - 63
  • [30] RADIOIMMUNOTHERAPY OF HUMAN COLONIC-CANCER XENOGRAFTS WITH Y-90-LABELED MONOCLONAL-ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN
    SHARKEY, RM
    KALTOVICH, FA
    SHIH, LB
    FAND, I
    GOVELITZ, G
    GOLDENBERG, DM
    CANCER RESEARCH, 1988, 48 (11) : 3270 - 3275
12345